ArticleOphthalmology science
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease.
Taylor McManus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
pooled itcites it